Skip to main content

Table 3 Success status and antiglaucoma medications in study and control groupsa

From: Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival

  Baseline Last follow-up
Study Group Control Group P-value** Study Group Control Group P-value**
Success status    0.50    0.28
 Absolute success 15 (78.9%) 16 (84.2%)   6 (31.6%) 10 (52.6%)  
 (maintain status) (5/15) (8/16)     
 (failed) (5/15) (6/16)     
 Qualified success 4 (21.1%) 3 (15.8%)   7 (36.8%) 3 (15.8%)  
 (maintain status) (2/4) (1/3)     
 (failed) (1/4) Zero     
 Failure   6 (31.6%) 6 (31.6%)  
Medications
 One or None 17 (89.5%) 19 (100%) 0.24 10 (52.6%) 15 (78.9%) 0.09
 Two or more 2 (10.5%) Zero   9 (47.4%) 4 (21.1%)  
  1. aData are presented as frequencies (%). Numbers are per eyes
  2. **P-value calculated using Chi-Square test